Market Snapshot
  • BSE Sensex: 77414.92 -0.25%
  • BSE 500: 33579.22 -0.39%
  • BSE 200: 10603.5 -0.39%
  • BSE 100: 24577.8 -0.38%
  • BSE MidCap: 41531.12 -0.68%
  • BSE SmallCap: 46638.13 -0.35%
  • BSE BANKEX: 59542.38 0.36%
  • BSE IT: 36122.71 -1.77%
  • Nifty 50: 23519.35 -0.31%
  • Nifty 500: 21339.55 -0.32%
  • Nifty 200: 12982.75 -0.36%
  • Nifty 100: 24057.35 -0.36%
  • Nifty Midcap 100: 51672.25 -0.32%
  • Nifty Small 100: 16095.7 -0.15%
  • Nifty IT: 36886.15 -1.76%
  • Nifty PSU Bank: 6263.4 -0.52%
News:
  • HAL signs Rs 62,700-cr deal wi...
  • RailTel Corp bags order worth ...
  • Niraj Cement?s JV bags contrac...
  • Advait Energy Transitions secu...
  • IRCON International secures Rs...
  • Euro to INR:  92.47 0.09%
  • Pound to INR:  110.90 0.24%
  • Yen to INR:  0.57 -0.18%
  • Dollar to INR:  85.76 0.04%
My Portfolio:
  • 0.00 0

Quotes

Back To Menu

WhiteOak Capital Pharma and Healthcare Fund-Reg (G) Equity - Pharma
INVEST

Plan: OPEN | Option: Growth | Ramesh Mantri

31 Mar 25 | 12:00 AM

12.74 0.00 (0.00%)

  • Underperforms

    27.98%

    Return (1Y)

    underperformed BSE Healthcare TRI by -20.33%

  • Less Volatile

    0.99%

    Standard Deviation (1Y)

    Lower Equity - Pharma by -0.22%

  • Inconsistent

    2/2

    Months

    Has underperformed Equity - Pharma

  • Value research rating

    Not Rated

Stock Composition

NAV

Critical Parameters

Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.

Returns

In last 1 year WhiteOak Capital Pharma and Healthcare Fund-Reg (G), has underperformed by -20.33% (CAGR difference)

27.98%

Underperforms

This is Alpha

Performance Chart for Rs

Invested in

30 Mar 2024

Risk

In last 1 year , the volatility of WhiteOak Capital Pharma and Healthcare Fund-Reg (G) is Lower than by -0.22%

0.99%

Less Volatile

Risk Meter

Peer Comparison on Risk - Return

Consistency

For 2 out of Last 2 Months, i.e 100% of the times It underperformed its benchmark, Equity - Pharma

Consistency Meter

Outperforming Stocks Vs. Underperforming Stocks

Based on the last 1year analysis, currently there are, the benchmark the benchmark

View Stock Composition